Cargando…

Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study

PURPOSE: Patients with Graves’ orbitopathy can present with asymmetric disease. The aim of this study was to identify clinical characteristics that distinguish asymmetric from unilateral and symmetric Graves’ orbitopathy. METHODS: This was a multi-centre study of new referrals to 13 European Group o...

Descripción completa

Detalles Bibliográficos
Autores principales: Perros, P., Žarković, M. P., Panagiotou, G. C., Azzolini, C., Ayvaz, G., Baldeschi, L., Bartalena, L., Boschi, A. M., Nardi, M., Brix, T. H., Covelli, D., Daumerie, C., Eckstein, A. K., Fichter, N., Ćirić, S., Hegedüs, L., Kahaly, G. J., Konuk, O., Lareida, J. J., Okosieme, O. E., Leo, M., Mathiopoulou, L., Clarke, L., Menconi, F., Morris, D. S., Orgiazzi, J., Pitz, S., Salvi, M., Muller, I., Knežević, M., Wiersinga, W. M., Currò, N., Dayan, C. M., Marcocci, C., Marinò, M., Möller, L., Pearce, S. H., Törüner, F., Bernard, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652741/
https://www.ncbi.nlm.nih.gov/pubmed/32474767
http://dx.doi.org/10.1007/s40618-020-01258-w
_version_ 1783607754183671808
author Perros, P.
Žarković, M. P.
Panagiotou, G. C.
Azzolini, C.
Ayvaz, G.
Baldeschi, L.
Bartalena, L.
Boschi, A. M.
Nardi, M.
Brix, T. H.
Covelli, D.
Daumerie, C.
Eckstein, A. K.
Fichter, N.
Ćirić, S.
Hegedüs, L.
Kahaly, G. J.
Konuk, O.
Lareida, J. J.
Okosieme, O. E.
Leo, M.
Mathiopoulou, L.
Clarke, L.
Menconi, F.
Morris, D. S.
Orgiazzi, J.
Pitz, S.
Salvi, M.
Muller, I.
Knežević, M.
Wiersinga, W. M.
Currò, N.
Dayan, C. M.
Marcocci, C.
Marinò, M.
Möller, L.
Pearce, S. H.
Törüner, F.
Bernard, M.
author_facet Perros, P.
Žarković, M. P.
Panagiotou, G. C.
Azzolini, C.
Ayvaz, G.
Baldeschi, L.
Bartalena, L.
Boschi, A. M.
Nardi, M.
Brix, T. H.
Covelli, D.
Daumerie, C.
Eckstein, A. K.
Fichter, N.
Ćirić, S.
Hegedüs, L.
Kahaly, G. J.
Konuk, O.
Lareida, J. J.
Okosieme, O. E.
Leo, M.
Mathiopoulou, L.
Clarke, L.
Menconi, F.
Morris, D. S.
Orgiazzi, J.
Pitz, S.
Salvi, M.
Muller, I.
Knežević, M.
Wiersinga, W. M.
Currò, N.
Dayan, C. M.
Marcocci, C.
Marinò, M.
Möller, L.
Pearce, S. H.
Törüner, F.
Bernard, M.
author_sort Perros, P.
collection PubMed
description PURPOSE: Patients with Graves’ orbitopathy can present with asymmetric disease. The aim of this study was to identify clinical characteristics that distinguish asymmetric from unilateral and symmetric Graves’ orbitopathy. METHODS: This was a multi-centre study of new referrals to 13 European Group on Graves’ Orbitopathy (EUGOGO) tertiary centres. New patients presenting over a 4 month period with a diagnosis of Graves’ orbitopathy were included. Patient demographics were collected and a clinical examination was performed based on a previously published protocol. Patients were categorized as having asymmetric, symmetric, and unilateral Graves’ orbitopathy. The distribution of clinical characteristics among the three groups was documented. RESULTS: The asymmetric group (n = 83), was older than the symmetric (n = 157) group [mean age 50.9 years (SD 13.9) vs 45.8 (SD 13.5), p = 0.019], had a lower female to male ratio than the symmetric and unilateral (n = 29) groups (1.6 vs 5.0 vs 8.7, p < 0.001), had more active disease than the symmetric and unilateral groups [mean linical Activity Score 3.0 (SD 1.6) vs 1.7 (SD 1.7), p < 0.001 vs 1.3 (SD 1.4), p < 0.001] and significantly more severe disease than the symmetric and unilateral groups, as measured by the Total Eye Score [mean 8.8 (SD 6.6) vs 5.3 (SD 4.4), p < 0.001, vs 2.7 (SD 2.1), p < 0.001]. CONCLUSION: Older age, lower female to male ratio, more severe, and more active disease cluster around asymmetric Graves’ orbitopathy. Asymmetry appears to be a marker of more severe and more active disease than other presentations. This simple clinical parameter present at first presentation to tertiary centres may be valuable to clinicians who manage such patients.
format Online
Article
Text
id pubmed-7652741
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-76527412020-11-12 Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study Perros, P. Žarković, M. P. Panagiotou, G. C. Azzolini, C. Ayvaz, G. Baldeschi, L. Bartalena, L. Boschi, A. M. Nardi, M. Brix, T. H. Covelli, D. Daumerie, C. Eckstein, A. K. Fichter, N. Ćirić, S. Hegedüs, L. Kahaly, G. J. Konuk, O. Lareida, J. J. Okosieme, O. E. Leo, M. Mathiopoulou, L. Clarke, L. Menconi, F. Morris, D. S. Orgiazzi, J. Pitz, S. Salvi, M. Muller, I. Knežević, M. Wiersinga, W. M. Currò, N. Dayan, C. M. Marcocci, C. Marinò, M. Möller, L. Pearce, S. H. Törüner, F. Bernard, M. J Endocrinol Invest Original Article PURPOSE: Patients with Graves’ orbitopathy can present with asymmetric disease. The aim of this study was to identify clinical characteristics that distinguish asymmetric from unilateral and symmetric Graves’ orbitopathy. METHODS: This was a multi-centre study of new referrals to 13 European Group on Graves’ Orbitopathy (EUGOGO) tertiary centres. New patients presenting over a 4 month period with a diagnosis of Graves’ orbitopathy were included. Patient demographics were collected and a clinical examination was performed based on a previously published protocol. Patients were categorized as having asymmetric, symmetric, and unilateral Graves’ orbitopathy. The distribution of clinical characteristics among the three groups was documented. RESULTS: The asymmetric group (n = 83), was older than the symmetric (n = 157) group [mean age 50.9 years (SD 13.9) vs 45.8 (SD 13.5), p = 0.019], had a lower female to male ratio than the symmetric and unilateral (n = 29) groups (1.6 vs 5.0 vs 8.7, p < 0.001), had more active disease than the symmetric and unilateral groups [mean linical Activity Score 3.0 (SD 1.6) vs 1.7 (SD 1.7), p < 0.001 vs 1.3 (SD 1.4), p < 0.001] and significantly more severe disease than the symmetric and unilateral groups, as measured by the Total Eye Score [mean 8.8 (SD 6.6) vs 5.3 (SD 4.4), p < 0.001, vs 2.7 (SD 2.1), p < 0.001]. CONCLUSION: Older age, lower female to male ratio, more severe, and more active disease cluster around asymmetric Graves’ orbitopathy. Asymmetry appears to be a marker of more severe and more active disease than other presentations. This simple clinical parameter present at first presentation to tertiary centres may be valuable to clinicians who manage such patients. Springer International Publishing 2020-05-30 2020 /pmc/articles/PMC7652741/ /pubmed/32474767 http://dx.doi.org/10.1007/s40618-020-01258-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Perros, P.
Žarković, M. P.
Panagiotou, G. C.
Azzolini, C.
Ayvaz, G.
Baldeschi, L.
Bartalena, L.
Boschi, A. M.
Nardi, M.
Brix, T. H.
Covelli, D.
Daumerie, C.
Eckstein, A. K.
Fichter, N.
Ćirić, S.
Hegedüs, L.
Kahaly, G. J.
Konuk, O.
Lareida, J. J.
Okosieme, O. E.
Leo, M.
Mathiopoulou, L.
Clarke, L.
Menconi, F.
Morris, D. S.
Orgiazzi, J.
Pitz, S.
Salvi, M.
Muller, I.
Knežević, M.
Wiersinga, W. M.
Currò, N.
Dayan, C. M.
Marcocci, C.
Marinò, M.
Möller, L.
Pearce, S. H.
Törüner, F.
Bernard, M.
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study
title Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study
title_full Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study
title_fullStr Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study
title_full_unstemmed Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study
title_short Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study
title_sort asymmetry indicates more severe and active disease in graves’ orbitopathy: results from a prospective cross-sectional multicentre study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652741/
https://www.ncbi.nlm.nih.gov/pubmed/32474767
http://dx.doi.org/10.1007/s40618-020-01258-w
work_keys_str_mv AT perrosp asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT zarkovicmp asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT panagiotougc asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT azzolinic asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT ayvazg asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT baldeschil asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT bartalenal asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT boschiam asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT nardim asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT brixth asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT covellid asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT daumeriec asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT ecksteinak asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT fichtern asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT cirics asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT hegedusl asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT kahalygj asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT konuko asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT lareidajj asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT okosiemeoe asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT leom asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT mathiopouloul asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT clarkel asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT menconif asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT morrisds asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT orgiazzij asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT pitzs asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT salvim asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT mulleri asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT knezevicm asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT wiersingawm asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT curron asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT dayancm asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT marcoccic asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT marinom asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT mollerl asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT pearcesh asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT torunerf asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT bernardm asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy
AT asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy